-
Understanding patient perceptions of the key components of Medication Adherence in PD: a multicenter, international study
-
Understanding the continuing educational needs of US clinicians managing OFF episodes in Parkinson’s disease
-
Unilateral Hypertrophic Olivary Degeneration in Anti-GAD-associated Encephalomyelitis
-
Unraveling the Potential of Specialized Allied Health Therapy in Parkinson’s Disease
-
Unravelling Hidden Mutations Behind the Heterozygos SYNE1 Genotype
-
Updated Parkinson’s disease motor subtypes classification and correlation to CSF HVA and 5-HIAA levels
-
Use of a wearable medical device for LCIG tube adjustment: a user case
-
Use of alternative healing for Parkinson’s disease in Kenya
-
Use of apomorphine infusion pump in the elderly population : a 5 years follw up study on efficacy, safety and tolerability in a cohort bases study
-
Use of bupivacaine in the evaluation of acute secondary cervical dystonia (CD)
-
USE OF NIGHT TIME CONTINUOUS SUBCUTANEOUS INFUSION OF APOMORPHINE (NCSAI) IN ADVANCED PARKINSON’S DISEASE: A SERIES OF 37 CASES.
-
Use of virtual reality devices for the monitoring of Parkinson’s disease
-
Using fMRI-based multivariate pattern analysis to differentiate between hyperkinetic movement disorders
-
Using quantitative susceptibility mapping and diffusion magnetic resonance imaging to identify structural features of early-stage Parkinson’s disease
-
Utilisation of the Clinical Frailty Scale to prompt transfer of patients with Parkinson’s disease from Neurology to Geriatric Medicine services.
-
Utilising multiple murine models to investigate sleep and circadian system dysfunction in PD
-
Utility of Seed Amplification Assay for Detecting α-synuclein in Formalin-Fixed Paraffin Embedded Skin Samples in Parkinson’s Disease
2022 International Congress
September 15-18, 2022. Madrid, Spain.